Literature DB >> 16906288

Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.

H H Ruocco1, I Lopes-Cendes, L M Li, M Santos-Silva, F Cendes.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that affects the striatum most severely. However, except for juvenile forms, relative preservation of the cerebellum has been reported. The objective of the present study was to perform MRI measurements of caudate, putamen, cerebral, and cerebellar volumes and correlate these findings with the length of the CAG repeat and clinical parameters. We evaluated 50 consecutive patients with HD using MRI volumetric measurements and compared them to normal controls. Age at onset of the disease ranged from 4 to 73 years (mean: 43.1 years). The length of the CAG repeat ranged from 40 to 69 (mean: 47.2 CAG). HD patients presented marked atrophy of the caudate and putamen, as well as reduced cerebellar and cerebral volumes. There was a significant correlation between age at onset of HD and length of the CAG repeat, as well as clinical disability and age at onset. The degree of basal ganglia atrophy correlated with the length of the CAG repeat. There was no correlation between cerebellar or cerebral volume and length of the CAG repeat. However, there was a tendency to a positive correlation between duration of disease and cerebellar atrophy. While there was a negative correlation of length of the CAG repeat with age at disease onset and with striatal degeneration, its influence on extrastriatal atrophy, including the cerebellum, was not clear. Extrastriatal atrophy occurs later in HD and may be related to disease duration.

Entities:  

Mesh:

Year:  2006        PMID: 16906288     DOI: 10.1590/s0100-879x2006000800016

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  16 in total

1.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

2.  Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.

Authors:  Susie M D Henley; Edward J Wild; Nicola Z Hobbs; Rachael I Scahill; Gerard R Ridgway; David G Macmanus; Roger A Barker; Nick C Fox; Sarah J Tabrizi
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

3.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Deborah L Harrington; James A Mills; Peggy C Nopoulos; Christopher A Ross; Jeffrey D Long; Dawei Liu; Holly K Westervelt; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2013

Review 4.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

5.  Early atrophy of pallidum and accumbens nucleus in Huntington's disease.

Authors:  Simon J A van den Bogaard; Eve M Dumas; Tanka P Acharya; Hans Johnson; Douglas R Langbehn; Rachael I Scahill; Sarah J Tabrizi; Mark A van Buchem; Jeroen van der Grond; Raymund A C Roos
Journal:  J Neurol       Date:  2010-10-09       Impact factor: 4.849

6.  Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.

Authors:  N Z Hobbs; J Barnes; C Frost; S M D Henley; E J Wild; K Macdonald; R A Barker; R I Scahill; N C Fox; S J Tabrizi
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-11       Impact factor: 3.825

7.  Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington disease.

Authors:  S E Dougherty; J L Reeves; E K Lucas; K L Gamble; M Lesort; R M Cowell
Journal:  Exp Neurol       Date:  2012-05-02       Impact factor: 5.330

Review 8.  Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review.

Authors:  Hannah S Bakels; Raymund A C Roos; Willeke M C van Roon-Mom; Susanne T de Bot
Journal:  Mov Disord       Date:  2021-10-12       Impact factor: 9.698

Review 9.  Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Authors:  Xin Du; Terence Y Pang
Journal:  Front Psychiatry       Date:  2015-03-09       Impact factor: 4.157

10.  Cerebellar contribution to anger recognition deficits in Huntington's disease.

Authors:  Wilfried Scharmüller; Rottraut Ille; Anne Schienle
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.